These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 38216972)

  • 21. RBM5 inhibits tumorigenesis of gliomas through inhibition of Wnt/β-catenin signaling and induction of apoptosis.
    Jiang Y; Sheng H; Meng L; Yue H; Li B; Zhang A; Dong Y; Liu Y
    World J Surg Oncol; 2017 Jan; 15(1):9. PubMed ID: 28061901
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Identification of proteins associated with transcription factors HOXA9 and E2A-PBX1 by tandem affinity purification].
    Shestakova EA; Boutin M; Bourassa S; Bonneil E; Bijl JJ
    Mol Biol (Mosk); 2017; 51(3):490-501. PubMed ID: 28707666
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The oncogene Nup98-HOXA9 induces gene transcription in myeloid cells.
    Ghannam G; Takeda A; Camarata T; Moore MA; Viale A; Yaseen NR
    J Biol Chem; 2004 Jan; 279(2):866-75. PubMed ID: 14561764
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Two isoforms of HOXA9 function differently but work synergistically in human MLL-rearranged leukemia.
    He M; Chen P; Arnovitz S; Li Y; Huang H; Neilly MB; Wei M; Rowley JD; Chen J; Li Z
    Blood Cells Mol Dis; 2012 Aug; 49(2):102-6. PubMed ID: 22633751
    [TBL] [Abstract][Full Text] [Related]  

  • 25. NUP98-HOXA9 bearing therapy-related myeloid neoplasm involves myeloid-committed cell and induces HOXA5, EVI1, FLT3, and MEIS1 expression.
    Burillo-Sanz S; Morales-Camacho RM; Caballero-Velázquez T; Vargas MT; García-Lozano JR; Falantes JF; Prats-Martín C; Bernal R; Pérez-Simón JA
    Int J Lab Hematol; 2016 Feb; 38(1):64-71. PubMed ID: 26418229
    [TBL] [Abstract][Full Text] [Related]  

  • 26. HOXA9 is required for survival in human MLL-rearranged acute leukemias.
    Faber J; Krivtsov AV; Stubbs MC; Wright R; Davis TN; van den Heuvel-Eibrink M; Zwaan CM; Kung AL; Armstrong SA
    Blood; 2009 Mar; 113(11):2375-85. PubMed ID: 19056693
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Upregulation of Flt3 is a passive event in Hoxa9/Meis1-induced acute myeloid leukemia in mice.
    Staffas A; Arabanian LS; Wei SY; Jansson A; Ståhlman S; Johansson P; Fogelstrand L; Cammenga J; Kuchenbauer F; Palmqvist L
    Oncogene; 2017 Mar; 36(11):1516-1524. PubMed ID: 27617578
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effects of HOXA9 Inhibitor DB818 on the Growth of Acute Myeloid Leukaemia Cells.
    Sonoda Y; Itoh M; Tohda S
    Anticancer Res; 2021 Apr; 41(4):1841-1847. PubMed ID: 33813389
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Deregulation of the HOXA9/MEIS1 axis in acute leukemia.
    Collins CT; Hess JL
    Curr Opin Hematol; 2016 Jul; 23(4):354-61. PubMed ID: 27258906
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Modeling the functional heterogeneity of leukemia stem cells: role of STAT5 in leukemia stem cell self-renewal.
    Heuser M; Sly LM; Argiropoulos B; Kuchenbauer F; Lai C; Weng A; Leung M; Lin G; Brookes C; Fung S; Valk PJ; Delwel R; Löwenberg B; Krystal G; Humphries RK
    Blood; 2009 Nov; 114(19):3983-93. PubMed ID: 19667399
    [TBL] [Abstract][Full Text] [Related]  

  • 31. HOXA9 Regulome and Pharmacological Interventions in Leukemia.
    Aryal S; Lu R
    Adv Exp Med Biol; 2024; 1459():405-430. PubMed ID: 39017854
    [TBL] [Abstract][Full Text] [Related]  

  • 32. HoxA9-mediated immortalization of myeloid progenitors requires functional interactions with TALE cofactors Pbx and Meis.
    Schnabel CA; Jacobs Y; Cleary ML
    Oncogene; 2000 Feb; 19(5):608-16. PubMed ID: 10698505
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Expression of HOXB4, PRDM16 and HOXA9 in Patients with Acute Myeloid Leukemia and Its Clinical Significance].
    Li L; Zhao CT; Cui BL; Wu SL; Liu XD; Su Z; Yang J; Wang W; Cui ZG; Zhao HG
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2016 Apr; 24(2):326-31. PubMed ID: 27150986
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Therapeutic antagonists of microRNAs deplete leukemia-initiating cell activity.
    Velu CS; Chaubey A; Phelan JD; Horman SR; Wunderlich M; Guzman ML; Jegga AG; Zeleznik-Le NJ; Chen J; Mulloy JC; Cancelas JA; Jordan CT; Aronow BJ; Marcucci G; Bhat B; Gebelein B; Grimes HL
    J Clin Invest; 2014 Jan; 124(1):222-36. PubMed ID: 24334453
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Smad4 binds Hoxa9 in the cytoplasm and protects primitive hematopoietic cells against nuclear activation by Hoxa9 and leukemia transformation.
    Quéré R; Karlsson G; Hertwig F; Rissler M; Lindqvist B; Fioretos T; Vandenberghe P; Slovak ML; Cammenga J; Karlsson S
    Blood; 2011 Jun; 117(22):5918-30. PubMed ID: 21471525
    [TBL] [Abstract][Full Text] [Related]  

  • 36. PBX3 is essential for leukemia stem cell maintenance in MLL-rearranged leukemia.
    Guo H; Chu Y; Wang L; Chen X; Chen Y; Cheng H; Zhang L; Zhou Y; Yang FC; Cheng T; Xu M; Zhang X; Zhou J; Yuan W
    Int J Cancer; 2017 Jul; 141(2):324-335. PubMed ID: 28411381
    [TBL] [Abstract][Full Text] [Related]  

  • 37. lncRNA RBM5-AS1 promotes cell proliferation and invasion by epigenetically silencing miR-132/212 in hepatocellular carcinoma cells.
    Mu JY; Tian JX; Chen YJ
    Cell Biol Int; 2021 Nov; 45(11):2201-2210. PubMed ID: 34019714
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The endothelin receptor type A is a downstream target of Hoxa9 and Meis1 in acute myeloid leukemia.
    Arabanian LS; Johansson P; Staffas A; Nilsson T; Rouhi A; Fogelstrand L; Palmqvist L
    Leuk Res; 2018 Dec; 75():61-68. PubMed ID: 30384975
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The nuclear splicing factor RNA binding motif 5 promotes caspase activation in human neuronal cells, and increases after traumatic brain injury in mice.
    Jackson TC; Du L; Janesko-Feldman K; Vagni VA; Dezfulian C; Poloyac SM; Jackson EK; Clark RS; Kochanek PM
    J Cereb Blood Flow Metab; 2015 Mar; 35(4):655-66. PubMed ID: 25586139
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Identification and characterisation of a novel antisense non-coding RNA from the RBM5 gene locus.
    Rintala-Maki ND; Sutherland LC
    Gene; 2009 Sep; 445(1-2):7-16. PubMed ID: 19559772
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.